Quick Answer
Beta Alanine Reaction Time Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Importantly, mechanistic evidence indicates that performance loss during repeated maximal efforts reflects an integrated disturbance in muscle function—encompassing substrate availability, metabolite/ionic perturbations, excitation–contraction coupling, and only later, more pronounced acid–base disruption—rather than a single dominant metabolite (–).
Key Takeaways
- 01Importantly, mechanistic evidence indicates that performance loss during repeated maximal efforts reflects an integrated disturbance in muscle function—encompassing substrate availability, metabolite/ionic perturbations, excitation–contraction coupling, and only later, more pronounced acid–base disruption—rather than a single dominant metabolite (–). [Liang Weibao (2026)]
- 02Consistent with this mechanism, contemporary meta-analytic evidence indicates the most reproducible ergogenic effects in high-intensity exercise tasks of approximately 1–4 min, where acid–base perturbation is more likely to be performance-limiting (). [Liang Weibao (2026)]
- 03Biopsy-based repeated-sprint experiments show that recovery of subsequent sprint performance is tightly associated with PCr resynthesis even when muscle pH remains depressed, suggesting that acid–base normalization is not a prerequisite for short-term restoration of repeated-sprint capacity (,). [Liang Weibao (2026)]
- 041 2 3 4 5 7 Repeated sprint ability (RSA) is a defining performance attribute in intermittent sports, characterized by repeated maximal or near-maximal efforts separated by brief recovery, with an ensuing decline in mechanical output across bouts (,). [Liang Weibao (2026)]
The current Migaku evidence database contains 2 reusable source documents for Beta Alanine Reaction Time Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- Importantly, mechanistic evidence indicates that performance loss during repeated maximal efforts reflects an integrated disturbance in muscle function—encompassing substrate availability, metabolite/ionic perturbations, excitation–contraction coupling, and only later, more pronounced acid–base disruption—rather than a single dominant metabolite (–). [Liang Weibao (2026); evidence level 1]
- Consistent with this mechanism, contemporary meta-analytic evidence indicates the most reproducible ergogenic effects in high-intensity exercise tasks of approximately 1–4 min, where acid–base perturbation is more likely to be performance-limiting (). [Liang Weibao (2026); evidence level 1]
- Biopsy-based repeated-sprint experiments show that recovery of subsequent sprint performance is tightly associated with PCr resynthesis even when muscle pH remains depressed, suggesting that acid–base normalization is not a prerequisite for short-term restoration of repeated-sprint capacity (,). [Liang Weibao (2026); evidence level 1]
- 1 2 3 4 5 7 Repeated sprint ability (RSA) is a defining performance attribute in intermittent sports, characterized by repeated maximal or near-maximal efforts separated by brief recovery, with an ensuing decline in mechanical output across bouts (,). [Liang Weibao (2026); evidence level 1]
- Conclusion This rigorously designed trial is expected to generate reliable evidence. [Fu J (2026); evidence level 2]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources
- No ergogeniceffect of β-alanine on repeated sprint ability: a systematic review and multilevel meta-analysis of randomized controlled trials
- Clinical effects of Yiqi-Yangyin-Huoxue granules in the management of type 2 diabetes mellitus and early vascular aging: a randomized, double-blind, placebo-controlled trial protocol.